期刊文献+

脂多糖注入黑质对大鼠黑质纹状体单胺类递质和行为的影响 被引量:5

Effects of intranigral injection of LPS on the levels of monoamine transmitters in the nigrostriatal system and behaviours in rats
下载PDF
导出
摘要 目的 探讨脂多糖 (L ipopolysaccharide,L PS)对大鼠行为学和黑质纹状体单胺类递质的影响。方法 采用立体定位注射 5μg L PS入大鼠脑黑质 ,在不同时间点观察大鼠注射阿朴吗啡后的旋转行为学 ,及采用HPL C测定黑质纹状体单胺类递质的含量变化。结果  L PS注射后 14、2 1、3 0 d,大鼠出现向注射侧的旋转行为 ,在黑质和纹状体 ,DA及其代谢产物随时间改变呈不同程度下降 (P<0 .0 5) ,而 5-HT仅有短暂下降 ,NA无变化。结论  L PS注入黑质特异性损害 DA能神经元 ,可降低黑质纹状体 DA及其代谢产物含量 。 ObjectiveTo investigate the effects of i ntranigral injection of lipopolysaccharide (LPS) on the levels of monoamine transmitters in the nigrostr iatal system and behaviours in rats. MethodsLPS was stereotaxically injected into substantia nigra (SN). At different survival times,rotation test induced by apomorphine was performed in all groups after LPS injection. The levels of monoa mine transmitters in the nigrostriatal system were measured by using HPLC-ECD. Results14,21,30days after injection of 5μg LPS into t he rat SN,the rotational behaviors were observed. The levels of DA and its metabolites in the SN and striatum decre ased,while the levels of 5-HT in the SN and striatum transiently changed and the lev els of NA showed no change. ConclusionLPS mainly affects th e dopaminergic system and can reduce the DA and its metabolites in the nigrostri atal. Also LPS can induce the rotational behaviors change in rats.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2004年第1期16-18,共3页 Journal of Apoplexy and Nervous Diseases
基金 国家自然科学基金资助项目( 30 1 70 334 ) 湖北省科技攻关重点项目 ( 2 0 0 1 AA 30 8B)
关键词 脂多糖注入黑质 大鼠 黑质纹状体 单胺类递质 行为特征 帕金森病 Lipopolysaccharide Monoamine transmitters Parkinson disease HPLC
  • 相关文献

参考文献9

  • 1Yokoyama C, Sasaki K. Regional expression of fos-like immunoreactivity in rat cerebral cortex after stress: restraint and intraperitoneal lipopolysaccharide[J]. Brain Res, 1999,816 (2):267-275.
  • 2Liu B, Du L, Hong JS. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation[J]. J Pharmacol Exp Ther,2000,293(2) :607-617.
  • 3Castano A,Lawson LJ,Fearn S,et al. Effects of a short period of vitamin E-deficient diet in the turnover for different neurotransmitters in substantial nigra and striatum of the rat[J]. Neuroscience, 1993,53(1) 179-185.
  • 4Brostein M,Perez-Otano L,Sun V,et al. Glia-dependent neurotoxity and neuroprotection in mesencephalic culture [J]. Brain Res, 1995,704(1): 112-116.
  • 5Jeohn GH,Cooper CL,Wilson B,et al. P38 MAP kinase is involved in Lipopolysaccharide-induced dopaminergic neuronal cell death in rat mesencephalic neuron-glia cultures[J]. Ann NY Acad Sci, 2002,962: 332-346.
  • 6Herrera AJ, Castano A, Venero JL, et al. The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system[J]. Neurobiol Dis, 2000,7 (4): 429-447.
  • 7孙圣刚,黎钢,曹学兵,童萼塘.帕金森病与炎症反应关系研究进展[J].中华神经科杂志,2003,36(6):401-403. 被引量:25
  • 8黎钢,曹学兵,孙圣刚.小胶质细胞与帕金森病[J].国外医学(神经病学.神经外科学分册),2003,30(1):77-80. 被引量:3
  • 9伦学庆.帕金森病实验动物模型研究进展[J].功能性和立体定向神经外科杂志,1999,12(2):59-62. 被引量:12

二级参考文献18

  • 1[1]Predborski S,Vila M,Jackson-Lewis V,et al.Reply:a new look at the pathogenesis of Parkinson disease.Trends Pharmacol Sci,2000,21 (5):165.
  • 2[2]Liberatore G,Jackson-Lewis V,Vukosavic S,et al.Inducible nitric oxide sythase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.Nat Med,1999,5 (12):1403-1409.
  • 3[3]Wu DC,Jackson V,Vila M,et al.Blockade of microglia activation is neuroprotective in the MPTP Mouse model of Parkinson disease.J Neurosci,2002,22 (5):1763-1771.
  • 4[4]Kim WG,Mohney RP,Wilson B,et al.Regional differences in susceptibility to Lipopolysaccharide-induced neurotoxicity in the rat brain:role of microglia.J Neurosci,2000,20 (16):6309-6316.
  • 5[5]Mirza B,Hadberg H,Thomsen P,et al.The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson' s disease.Neuroscieece,2000,95 (2):425-432.
  • 6[6]Hirsch EC,Hunot S,Damier P,et al.Glia cells and inflammation in Parkinson' s disease:a role in neurodegeneration? Ann Neurol,1998,44 (3,Suppl1):Sl15-S120.
  • 7[7]Herrera AJ,Castano A,Venero JL,et al.The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system.Neurobiol Dis,2000,7 (4):429-447.
  • 8[8]Liu B,Jiang JW,Wilson BC,et al.Systemic infusion of Naloxone reduces degeneration of rat substantial nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide.J Pharmacol Exp Ther,2000,295 (1):125-132.
  • 9[9]He Y,Appel S,Le W.Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum.Brain Res,2001,909 (1,2):187-193.
  • 10[10]Liu B,Du L,Hong JS.Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation.J Pharmacol Exp Ther,2000,293 (2):607-617.

共引文献36

同被引文献39

  • 1代玉桥,金道忠,邓小华,李建明,刘正清,罗学港,雷德亮.雷公藤甲素对LPS诱导的海马炎症过程中COX-2和iNOS表达的影响[J].神经解剖学杂志,2006,22(5):521-524. 被引量:9
  • 2Dalrymple SA. P38 mitogen activated protein kinase as a therapeutic target for Alzheimer's disease[J ]. J Mol Neurosci, 2002, 19 (3) : 295-299.
  • 3Koistinaho M, Kettunen MI,Godsteins G, et al. Beta-amyoid precursor protein transgenic mice that harbor diffuse A beta deports but do not form plaques show increased ischemic vulnerability; Roh of inflammation[J].J Proc Natl Acad Sci USA,2002, 99(3) :1610-1615.
  • 4Hensley K, Floyd RA, Zheng NY, et al. P38 kinase is activated in the Alzheimer' s disease brain [J ]. J Neurochem, 1999, 72 (5) : 2053-2058.
  • 5Tsukamoto E, Hashimoto Y, Kanekura K, et al. Characterization of the toxic mechanism triggered by Alzheimer' s amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cells [J ]. J Neurosci Res, 2003, 73 : 627-636.
  • 6Akiyama H, Arai T, Kondo H, et al. Cell mediators of inflammation in the Alzheimer disease brain [ J ]. J Alzheimer Dis Assoc Discord, 2000,14(Suppl 1) :S47-53.
  • 7McGeer PL, SchulzerM, McGeer EG. Arthritis and anti2 inflammatory agents as possible protective factors for Alzheimer's disease:a review of 17 epldemiologic studies[J] .J Neurology, 1996, 47:425.
  • 8Martino G; Furlan R, Brambilla E, et al. Cytokines and immunity in multiple sclerosis the signa hypothesis[J ]. J Neuroimmunol, 2000,109: 3-9.
  • 9Li Y, Liu L, Barger SW. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through ap38MAPK pathway[J ]. J Neurosci, 2003,23 (5) : 1605-1611.
  • 10Herrera A J, Tomas M, Venero JL, et al . Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons[J]. J Neurol Transm, 2005,112(1) : 111-119.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部